GlobeNewswire Inc.··Schall Law FirmErasca Stock Plummets 48% on Patent Infringement Claims; Class Action Probe Launched
Erasca faces securities fraud investigation after disclosing patent infringement letter from Revolution Medicines, triggering massive stock collapse.
RVMDRVMDWERASstock declinesecurities litigation